Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Samantha Ly"'
Autor:
JoAnn Lindenfeld, Neal K. Lakdawala, Michael M. Givertz, Samantha Ly, Kevin J. Anstrom, Finnian R. Mc Causland, Lynne W. Stevenson, Jie-Lena Sun, Jonathan W. Cunningham
Publikováno v:
Clinical Cardiology
Background In patients hospitalized with acute heart failure (AHF), low urine sodium concentration (U Na) after diuretic treatment may identify patients at risk for longer length of stay (LOS) and adverse events. We investigated the prognostic signif
Autor:
Jacquelyn-My Do, Desiree Tobin, Shannon A. Johnson, Mariah Bundy, Melissa Chin, Samantha Ly, Sara Temiyasathit, Scott Kinlay, Margot Quinn
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 1, p e0211152 (2019)
PLoS ONE, Vol 14, Iss 1, p e0211152 (2019)
In healthy arteries, blood flow is regulated by microvascular tone assessed by changes in blood flow volume and vascular resistance to endothelium-dependent and -independent vasodilators. We developed a novel method of using intravascular ultrasound
Autor:
Samantha Ly, Sara Temiyasathit, David R. Gagnon, Kyle J. Smoot, Scott Kinlay, David P. Faxon, J. Michael Gaziano, Omar K. Siddiqi, Melissa M. Young, Kelly Cho, Alyssa B. Dufour
Patients with chronic kidney disease (CKD) are at high risk of death or myocardial infarction (MI) after percutaneous coronary interventions (PCI). We assessed whether prolonged dual antiplatelet therapy beyond the recommended 12 months may prevent a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1956040511c607b95c33385b1b842ab
https://europepmc.org/articles/PMC4580134/
https://europepmc.org/articles/PMC4580134/
Autor:
Arun K. Thukkani, Kush Agrawal, David R. Gagnon, Lillian Prince, Scott Kinlay, David P. Faxon, Alyssa B. Dufour, J. Michael Gaziano, Kyle J. Smoot, Galina Sokolovskaya, Kelly Cho, Sara Temiyasathit, Samantha Ly
Publikováno v:
Journal of the American College of Cardiology. 66(10)
Background Recent large clinical trials show lower rates of late cardiovascular events by extending clopidogrel >12 months after percutaneous coronary revascularization (PCI). However, concerns of increased bleeding have elicited support for limiting
Autor:
Jacquelyn Do, David P Faxon, David R. Gagnon, Adrianna Nava, Samantha Ly, Neil J Wimmer, Kelly Cho, Kyle J. Smoot, John Michael Gaziano, Scott Kinlay, Simon Ostrowski, Sara Temiyasathit, Galina Sokolovskaya
Publikováno v:
Circulation. 130
Introduction: Clopidogrel up to 12 months after an acute coronary syndrome (ACS) lowers the risk of major adverse coronary events. Guidelines recommend clopidogrel for 12 months after coronary intervention (PCI) with bare-metal (BMS) or drug-eluting
Autor:
Samantha Ly Lau, Chun Gong, Oscar G.W. Wong, Ui-Soon Khoo, Nan Yang, Janice Wing-hang Tsang, Luduo Zhang, Annie N.Y. Cheung, Kelvin Y.K. Chan
Publikováno v:
Cancer research. 73(1)
Gene expression profiling aimed at classifying and prognosing breast cancer has yielded signatures with little, if any, concordance. However, expression arrays used in these studies do not discriminate alternate RNA splice isoforms that vary widely i